Global Prosthetic Heart Valves Market 2020-2024
SKU ID : TNV-16372052 | Publishing Date : 27-Aug-2020 | No. of pages : 120
Detailed TOC of Global Prosthetic Heart Valves Market 2020-2024
• Executive Summaryo Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 - 2024
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o Transcatheter heart valves - Market size and forecast 2019-2024
o Tissue heart valves - Market size and forecast 2019-2024
o Mechanical heart valves - Market size and forecast 2019-2024
o Market opportunity by Product
• Market Segmentation by End-user
o Hospitals
o ASCs
o Specialty cardiac centers
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o Europe - Market size and forecast 2019-2024
o North America - Market size and forecast 2019-2024
o APAC - Market size and forecast 2019-2024
o ROW - Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Volume drivers – Demand led growth
o Volume drivers – External factors
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Abbott Laboratories
o Boston Scientific Corp.
o Colibri Heart Valve LLC
o CryoLife Inc.
o Edwards Lifesciences Corp.
o Labcor Laboratórios LTDA
o Lepu Medical Technology (Beijing) Co. Ltd.
o LivaNova Plc
o Medtronic Plc
o MitrAssist Ltd.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global - Market size and forecast 2019 - 2024 ($ million)
• 13: Global market: Year-over-year growth 2019 - 2024 (%)
• 14: Five forces analysis 2019 & 2024
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition - Five forces 2019
• 21: Transcatheter heart valves - Market size and forecast 2019-2024 ($ million)
• 22: Transcatheter heart valves - Year-over-year growth 2019-2024 (%)
• 23: Tissue heart valves - Market size and forecast 2019-2024 ($ million)
• 24: Tissue heart valves - Year-over-year growth 2019-2024 (%)
• 25: Mechanical heart valves - Market size and forecast 2019-2024 ($ million)
• 26: Mechanical heart valves - Year-over-year growth 2019-2024 (%)
• 27: Customer landscape
• 28: Impact of drivers and challenges
• 29: Vendor landscape
• 30: Landscape disruption
• 31: Industry risks
• 32: Vendors covered
• 33: Market positioning of vendors
• 34: Abbott Laboratories - Overview
• 35: Abbott Laboratories - Business segments
• 36: Abbott Laboratories - Key offerings
• 37: Abbott Laboratories - Key customers
• 38: Abbott Laboratories - Segment focus
• 39: Boston Scientific Corp. - Overview
• 40: Boston Scientific Corp. - Business segments
• 41: Boston Scientific Corp. - Key offerings
• 42: Boston Scientific Corp. - Key customers
• 43: Boston Scientific Corp. - Segment focus
• 44: Colibri Heart Valve LLC - Overview
• 45: Colibri Heart Valve LLC - Product and service
• 46: Colibri Heart Valve LLC - Key offerings
• 47: Colibri Heart Valve LLC - Key customers
• 48: Colibri Heart Valve LLC - Segment focus
• 49: CryoLife Inc. - Overview
• 50: CryoLife Inc. - Business segments
• 51: CryoLife Inc. - Key offerings
• 52: CryoLife Inc. - Key customers
• 53: CryoLife Inc. - Segment focus
• 54: Edwards Lifesciences Corp. - Overview
• 55: Edwards Lifesciences Corp. - Business segments
• 56: Edwards Lifesciences Corp. - Key offerings
• 57: Edwards Lifesciences Corp. - Key customers
• 58: Edwards Lifesciences Corp. - Segment focus
• 59: Labcor Laboratórios LTDA - Overview
• 60: Labcor Laboratórios LTDA - Product and service
• 61: Labcor Laboratórios LTDA - Key offerings
• 62: Labcor Laboratórios LTDA - Key customers
• 63: Labcor Laboratórios LTDA - Segment focus
• 64: Lepu Medical Technology (Beijing) Co. Ltd. - Overview
• 65: Lepu Medical Technology (Beijing) Co. Ltd. - Product and service
• 66: Lepu Medical Technology (Beijing) Co. Ltd. - Key offerings
• 67: Lepu Medical Technology (Beijing) Co. Ltd. - Key customers
• 68: Lepu Medical Technology (Beijing) Co. Ltd. - Segment focus
• 69: LivaNova Plc - Overview
• 70: LivaNova Plc - Business segments
• 71: LivaNova Plc - Key offerings
• 72: LivaNova Plc - Key customers
• 73: LivaNova Plc - Segment focus
• 74: Medtronic Plc - Overview
• 75: Medtronic Plc - Business segments
• 76: Medtronic Plc - Key offerings
• 77: Medtronic Plc - Key customers
• 78: Medtronic Plc - Segment focus
• 79: MitrAssist Ltd. - Overview
• 80: MitrAssist Ltd. - Product and service
• 81: MitrAssist Ltd. - Key offerings
• 82: MitrAssist Ltd. - Key customers
• 83: MitrAssist Ltd. - Segment focus
• 84: Currency conversion rates for US$
• 85: Research Methodology
• 86: Validation techniques employed for market sizing
• 87: Information sources
• 88: List of abbreviations